Congenital factor XIII deficiency: comprehensive overview of the FranceCoag cohort

Br J Haematol. 2020 Jan;188(2):317-320. doi: 10.1111/bjh.16133. Epub 2019 Aug 14.

Abstract

This FranceCoag network study assessed 33 patients with congenital factor XIII (FXIII) deficiency presenting FXIII levels <10 iu/dl. Diagnosis was based on abnormal bleeding in 29 patients, a positive family history in 2, recurrent miscarriages in 1 and was fortuitous in 1. Eighteen patients (62·1%) presented life-threatening umbilical or intracranial haemorrhages (ICH). Seven of the 15 patients who experienced ICH were diagnosed but untreated, including 3 with secondary neurological sequelae. All pregnancies without prophylaxis (26/26) led to miscarriages versus 3/16 with prophylaxis. In patients exhibiting FXIII levels <10 iu/dl, prophylaxis could be discussed at diagnosis and at pregnancy. Further controlled prospective studies are needed.

Keywords: epidemiology; factor XIII; prophylaxis; rare bleeding disorder; registry.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Adolescent
  • Adult
  • Cohort Studies
  • Factor XIII Deficiency*
  • Female
  • Humans
  • Male
  • Retrospective Studies
  • Young Adult